Clinical Study Results Our numbers don't lie
Additionally, these agonists promote CD4 + T cells to release IFN-
Ito et al., 2023) (this may be particularly relevant for the destabilization of myelin), synaptic dysfunction (Tu et al., 2014) (this includes impairment of signaling at the axo-myelinic synapse, crucial for survival of the myelinated axon
Furthermore, we observed a significant decrease in the branched-chain amino acids, valine and isoleucine, and a depletion in glutamate and cysteine levels
Additionally, for patients with heart disease, IV therapy can be used to administer certain medications intravenously to improve heart function, manage arrhythmias, or treat heart failure